GOLT1B and cancer: The amplification of GOLT1B has been reported to be correlated with a worse prognosis in patients with resected LUAD.[15] Consistent with previous studies, our study further confirmed that high expression levels of GOLT1B are linked to poor prognosis in many types of cancer.